Chemoinformaics analysis of alpha-Vetispirene
Molecular Weight | 202.341 | nRot | 1 |
Heavy Atom Molecular Weight | 180.165 | nRig | 12 |
Exact Molecular Weight | 202.172 | nRing | 2 |
Solubility: LogS | -4.897 | nHRing | 0 |
Solubility: LogP | 4.6 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 39.7194 |
nHD | 0 | BPOL | 22.0706 |
QED | 0.543 |
Synth | 4.849 |
Natural Product Likeliness | 2.164 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.073 |
Pgp-sub | 0 |
HIA | 0.002 |
CACO-2 | -4.449 |
MDCK | 0.00000934 |
BBB | 0.24 |
PPB | 0.943047 |
VDSS | 2.489 |
FU | 0.056983 |
CYP1A2-inh | 0.876 |
CYP1A2-sub | 0.661 |
CYP2c19-inh | 0.783 |
CYP2c19-sub | 0.884 |
CYP2c9-inh | 0.526 |
CYP2c9-sub | 0.726 |
CYP2d6-inh | 0.577 |
CYP2d6-sub | 0.743 |
CYP3a4-inh | 0.429 |
CYP3a4-sub | 0.331 |
CL | 11.782 |
T12 | 0.213 |
hERG | 0.085 |
Ames | 0.006 |
ROA | 0.089 |
SkinSen | 0.945 |
Carcinogencity | 0.357 |
EI | 0.829 |
Respiratory | 0.729 |
NR-Aromatase | 0.438 |
Antiviral | Yes |
Prediction | 0.824764 |